Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity
Authors:
- U. HaddingUHU. Hadding
- E. EtschenbergEEE. Etschenberg
- E. GrafEGE. Graf
- S. LeyckSLS. Leyck
- J. WinkelmannJWJ. Winkelmann
- M.J. ParnhamMPM.J. Parnham
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (6) , 729-737
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Influence of rosmarinic acid on opsonization and intracellular killing ofEschericha coli andStaphylococcus aureus by porcine and human polymorphonuclear leucocytesInflammation Research, 1987
- Inhibition of experimentally induced microvascular injury by rosmarinic acidInflammation Research, 1986
- Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytesInflammation Research, 1986
- Regulation of the macrophage oxidative burst by mediators: Effects of inhibitorsInflammation Research, 1985
- Platelet Activating Factor (PAF) induces the oxidative burst in macrophagesInternational Journal of Immunopharmacology, 1983
- Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.Journal of Experimental Medicine, 1981
- A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in cultureJournal of Immunological Methods, 1980
- Platelet Activation: a New Biological Activity of Guinea‐pig C3a AnaphylatoxinScandinavian Journal of Immunology, 1978
- Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis — IImmunochemistry, 1970
- A new ultrasensitive method for the determination of proteolytic activityClinica Chimica Acta, 1968